Pharmacokinetic effects of curcumin on docetaxel mediated by OATP1B1, OATP1B3 and CYP450s.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Drug Metabolism and Pharmacokinetics

• Publication date

  2016-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.dmpk.2016.02.005PMID 27452633
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.

  2017cited by this paper
• Overuse of Chest CT in Patients With Stage I and II Breast Cancer: An Opportunity to Increase Guidelines Compliance at an NCCN Member Institution.

  2017cited by this paper
• Human OATP1B1, OATP1B3 and OATP1A2 can mediate the in vivo uptake and clearance of docetaxel

  2015cited by this paper
• Curcumin Enhances Docetaxel-Induced Apoptosis of 8505C Anaplastic Thyroid Carcinoma Cells

  2014cited by this paper
• Prediction of Organic Anion-Transporting Polypeptide 1B1- and 1B3-Mediated Hepatic Uptake of Statins Based on Transporter Protein Expression and Activity Data

  2014cited by this paper
• Effect of a herbal extract containing curcumin and piperine on midazolam, flurbiprofen and paracetamol (acetaminophen) pharmacokinetics in healthy volunteers

  2013cited by this paper
• Incorporation of ABCB1-mediated transport into a physiologically-based pharmacokinetic model of docetaxel in mice

  2013cited by this paper
• Pharmacokinetics and Biodistribution Study of Paclitaxel Liposome in Sprague-Dawley Rats and Beagle Dogs by Liquid Chromatography-Tandem Mass Spectrometry

  2013cited by this paper
• Prediction of the in vivo OATP1B1-mediated drug-drug interaction potential of an investigational drug against a range of statins.

  2012cited by this paper
• Identification of Amino Acids Essential for Estrone-3-Sulfate Transport within Transmembrane Domain 2 of Organic Anion Transporting Polypeptide 1B1

  2012cited by this paper
• Influence of SLCO1B3 haplotype-tag SNPs on docetaxel disposition in Chinese nasopharyngeal cancer patients.

  2012cited by this paper
• Synergistic antitumor efficiency of docetaxel and curcumin against lung cancer.

  2012cited by this paper
• A Comprehensive Assessment of Repaglinide Metabolic Pathways: Impact of Choice of In Vitro System and Relative Enzyme Contribution to In Vitro Clearance

  2012cited by this paper
• Influence of Polymorphic OATP1B-Type Carriers on the Disposition of Docetaxel

  2012cited by this paper
• Effects of oral curcumin on the pharmacokinetics of intravenous and oral etoposide in rats: possible role of intestinal CYP3A and P-gp inhibition by curcumin.

  2011cited by this paper
• The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of docetaxel in nasopharyngeal carcinoma patients

  2011cited by this paper
• Predicting drug disposition via application of a Biopharmaceutics Drug Disposition Classification System.

  2010cited by this paper
• Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer

  2010cited by this paper
• Interactions of Green Tea Catechins with Organic Anion-Transporting Polypeptides

  2009cited by this paper
• Advances in studies on curcumin

  2009cited by this paper
• Pharmacogenetic Pathway Analysis of Docetaxel Elimination

  2009cited by this paper
• Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer

  2008cited by this paper
• Paclitaxel and docetaxel in the treatment of breast cancer.

  2008cited by this paper
• The Effect of Gemfibrozil on Repaglinide Pharmacokinetics Persists for at Least 12 h After the Dose: Evidence for Mechanism‐based Inhibition of CYP2C8 In Vivo

  2008cited by this paper
• Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption.

  2008cited by this paper
• Docetaxel in the treatment of advanced non-small-cell lung cancer

  2008cited by this paper
• Curcumin as "Curecumin": from kitchen to clinic.

  2008cited by this paper
• Paclitaxel and docetaxel in the treatment of breast cancer

  2008cited by this paper
• Gemfibrozil and its glucuronide inhibit the hepatic uptake of pravastatin mediated by OATP1B1

  2007cited by this paper
• Curcumin Inhibits Tumor Growth and Angiogenesis in Ovarian Carcinoma by Targeting the Nuclear Factor-κB Pathway

  2007cited by this paper
• Impact of Curcumin-Induced Changes in P-Glycoprotein and CYP3A Expression on the Pharmacokinetics of Peroral Celiprolol and Midazolam in Rats

  2007cited by this paper
• Unexpected effect of concomitantly administered curcumin on the pharmacokinetics of talinolol in healthy Chinese volunteers

  2007cited by this paper
• Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolism.

  2007cited by this paper
• Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway.

  2007cited by this paper
• Clinical Pharmacokinetics of Docetaxel

  2006cited by this paper
• GLUCURONIDATION CONVERTS GEMFIBROZIL TO A POTENT, METABOLISM-DEPENDENT INHIBITOR OF CYP2C8: IMPLICATIONS FOR DRUG-DRUG INTERACTIONS

  2006cited by this paper
• Curcumin modulates drug metabolizing enzymes in the female Swiss Webster mouse.

  2006cited by this paper
• MRP2 (ABCC2) transports taxanes and confers paclitaxel resistance and both processes are stimulated by probenecid

  2005cited by this paper
• Identification of OATP1B3 as a high-affinity hepatocellular transporter of paclitaxel

  2005cited by this paper
• Polymorphic Organic Anion Transporting Polypeptide 1B1 is a Major Determinant of Repaglinide Pharmacokinetics

  2005cited by this paper
• Predicting Drug Disposition via Application of BCS: Transport/Absorption/ Elimination Interplay and Development of a Biopharmaceutics Drug Disposition Classification System

  2004cited by this paper
• Biochemical mechanism of modulation of human P-glycoprotein (ABCB1) by curcumin I, II, and III purified from Turmeric powder.

  2004cited by this paper
• Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics and pharmacodynamics of repaglinide: potentially hazardous interaction between gemfibrozil and repaglinide

  2003cited by this paper
• Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer.

  2001cited by this paper
• Role of intestinal P-glycoprotein in the plasma and fecal disposition of docetaxel in humans.

  2000cited by this paper
• Clinical Pharmacokinetics of Docetaxel

  1999cited by this paper
• Inhibitory effect of dietary curcumin on skin carcinogenesis in mice.

  1997cited by this paper
• Hepatic biotransformation of docetaxel (Taxotere) in vitro: involvement of the CYP3A subfamily in humans.

  1996cited by this paper
• NCCN Small-Cell Lung Cancer Practice Guidelines. The National Comprehensive Cancer Network.

  1996cited by this paper
• Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice.

  1994cited by this paper
• Pharmacology of Curcuma longa

  1991cited by this paper

• Role of solute carrier transporters in the biodistribution and toxicity of chemotherapeutic drugs.

  2026cites this paper
• Oral anticancer drug delivery: Strategies for improving bioavailability

  2026cites this paper
• Elucidation of the compatibility mechanism of Yuanhuzhitong prescription in view of CYP-mediated herbal inter-component interactions.

  2025cites this paper
• Strategic modulation of CYP isoenzymes and P-gp by a natural bioenhancer: A novel approach to enhance oral paclitaxel bioavailability across In vivo, In situ, and Ex vivo models.

  2025cites this paper
• Emerging evidence of inter-organ interaction on drug transporters under liver injury.

  2025cites this paper
• Synthetic Curcumin Analogs in Nephrotoxicity: Mechanisms and Therapeutic Advances.

  2025cites this paper
• Drug Interactions of Imperatorin and Curcumin on Macitentan in vitro and in vivo

  2025cites this paper
• Rifampin- and Silymarin-Mediated Pharmacokinetic Interactions of Exogenous and Endogenous Substrates in a Transgenic OATP1B Mouse Model.

  2024cites this paper
• The Bright Side of Curcumin: A Narrative Review of Its Therapeutic Potential in Cancer Management

  2024cites this paper
• Strategies to enhance the response of liver cancer to pharmacological treatments.

  2024cites this paper
• The Use of an Antioxidant Enables Accurate Evaluation of the Interaction of Curcumin on Organic Anion-Transporting Polypeptides 4C1 by Preventing Auto-Oxidation

  2024influential citation
• Influence of dietary bioactive compounds on the bioavailability and excretion of PFOA and its alternative HFPO-TA: Mechanism exploration.

  2023cites this paper
• Targeting a xenobiotic transporter to ameliorate vincristine-induced sensory neuropathy

  2023cites this paper
• Pharmacogenomics in Cytotoxic Chemotherapy of Cancer.

  2022cites this paper
• Trivariate Linear Regression and Machine Learning Prediction of Possible Roles of Efflux Transporters in Estimated Intestinal Permeability Values of 301 Disparate Chemicals.

  2022cites this paper
• Potential Herb–Drug Interactions in the Management of Age-Related Cognitive Dysfunction

  2021cites this paper
• Food constituent– and herb–drug interactions in oncology: Influence of quantitative modelling on Drug labelling

  2021cites this paper
• Possible Mechanisms and Special Clinical Considerations of Curcumin Supplementation in Patients with COVID-19.

  2021cites this paper
• Bio-Nanocarriers for Lung Cancer Management: Befriending the Barriers

  2021cites this paper
• Cytochrome P450 Inhibition

  2020cites this paper
• Solute Carrier Transportome in Chemotherapy-Induced Adverse Drug Reactions.

  2020cites this paper
• Analysis of polyphenolics

  2020cites this paper
• Altered Biodistribution of 68Ga-DOTATOC.

  2020cites this paper
• Surface-engineered nanostructured lipid carrier systems for synergistic combination oncotherapy of non-small cell lung cancer

  2020cites this paper
• Transporters (OATs and OATPs) contribute to illustrate the mechanism of medicinal compatibility of ingredients with different properties in yuanhuzhitong prescription

  2020cites this paper
• Organic anion‑transporting polypeptides contribute to the uptake of curcumin and its main metabolites by human breast cancer cells: Impact on antitumor activity.

  2019cites this paper
• The differential cellular uptake of curcuminoids in vitro depends dominantly on albumin interaction.

  2019cites this paper
• LC478, a Novel Di-Substituted Adamantyl Derivative, Enhances the Oral Bioavailability of Docetaxel in Rats

  2019cites this paper
• Curcumin as an In Vivo Selective Intestinal Breast Cancer Resistance Protein Inhibitor in Cynomolgus Monkeys

  2018influential citation
• Utility of curcumin for the treatment of diabetes mellitus: Evidence from preclinical and clinical studies

  2018cites this paper
• Validated UPLC-MS/MS method for the quantification of dasatinib in plasma: Application to pharmacokinetic interaction studies with nutraceuticals in Wistar rats

  2018cites this paper
• OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity

  2018cites this paper
• Transporter-mediated natural product–drug interactions for the treatment of cardiovascular diseases

  2017influential citation
• The effects of dietary and herbal phytochemicals on drug transporters☆

  2017cites this paper
• Pharmacokinetic interactions of curcuminoids with conventional drugs: A review.

  2017cites this paper
• Curcumin as a clinically-promising anti-cancer agent: pharmacokinetics and drug interactions

  2017cites this paper
• The potential role of curcumin in prostate cancer: the importance of optimizing pharmacokinetics in clinical studies.

  2016cites this paper